Orangeburg, New York Clinical Trials

A listing of Orangeburg, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

platelet count
squamous cell lung carcinoma
paclitaxel
immunodeficiency
carcinoma
Valley Health System-Hematology/Oncology
 (5.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

The investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dose and volume of radiation therapy to control soft tissue sarcoma after surgery. They also want to find …

soft tissue sarcoma
sarcoma
serum pregnancy test
primary tumor
sarcoma of the extremity
Memorial Sloan Kettering Bergen (All protocol activities)
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given …

platelet count
follicular thyroid cancer
pet/ct scan
malabsorption syndrome
pet/ct
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

cns tumor
pharyngitis
breast cancer
chills
dyspnea
Memorial Sloan Kettering Bergen (All protocol Activities)
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Study researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a safe and effective treatment for …

Memorial Sloan Kettering Bergen (Limited Protocol Activities)
 (4.6 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +6 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

deficiency
imiglucerase
eliglustat
gaucher disease
Investigational Site Number 840039
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

gaa gene
myozyme
glycogen storage disease type ii
replacement therapy
deficiency
Investigational Site Number 840039
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

fabry's disease
agalsidase beta
fabrazyme
alpha-galactosidase
deficiency
Investigational Site Number 840039
 (9.9 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +136 other locations
Micra AV Transcatheter Pacing System Post-Approval Registry

Medtronic is sponsoring the Micra AV Registry using the Micra AV system for continued surveillance of chronic atrioventricular synchronous pacing as intended, through the collection of data based on routine clinical care practice, following commercial release. The Micra AV Registry is conducted within Medtronic's Product Surveillance Registry (PSR) platform.

The Valley Hospital
 (8.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.

dilation and curettage
endometrioid carcinoma
skin carcinoma
adenocarcinoma
skin cancer
Memorial Sloan Kettering Bergen (All protocol activities)
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +15 other locations